Enveric Biosciences, Inc. Email Format

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Enveric Biosciences, Inc. is a Cambridge, Massachusetts-based biotechnology company focused on developing small-molecule therapies that promote neuroplasticity to address depression, anxiety, addiction, and related neuropsychiatric conditions. It operates around a discovery framework called Psybrary, which underpins a pipeline of novel chemical entities for mental health indications. The lead candidate, EB-003, is described as a potential first-in-class neuroplastogen intended to enhance neural plasticity without inducing hallucinatory effects, with clinical development as its near-term objective. Beyond EB-003, the company pursues out-licensing of other patented Psybrary compounds to third-party licensees to enable varied approaches to patient care.

Enveric sits in the pharmaceutical manufacturing sector as a smaller biotech company emphasizing external collaboration to advance its portfolio. A recent development includes a January 2026 partnership with Totec Pharma to extend licensing arrangements, illustrating its strategy of leveraging collaborations to extend its pipeline.

Sign up for free to view info

Company overview Employee directory